Anthony Atala to Hep G2 Cells
This is a "connection" page, showing publications Anthony Atala has written about Hep G2 Cells.
Connection Strength
0.132
-
Skardal A, Devarasetty M, Forsythe S, Atala A, Soker S. A reductionist metastasis-on-a-chip platform for in vitro tumor progression modeling and drug screening. Biotechnol Bioeng. 2016 09; 113(9):2020-32.
Score: 0.034
-
Baptista PM, Moran EC, Vyas D, Ribeiro MH, Atala A, Sparks JL, Soker S. Fluid Flow Regulation of Revascularization and Cellular Organization in a Bioengineered Liver Platform. Tissue Eng Part C Methods. 2016 Mar; 22(3):199-207.
Score: 0.033
-
Bhise NS, Manoharan V, Massa S, Tamayol A, Ghaderi M, Miscuglio M, Lang Q, Shrike Zhang Y, Shin SR, Calzone G, Annabi N, Shupe TD, Bishop CE, Atala A, Dokmeci MR, Khademhosseini A. A liver-on-a-chip platform with bioprinted hepatic spheroids. Biofabrication. 2016 Jan 12; 8(1):014101.
Score: 0.033
-
Skardal A, Devarasetty M, Rodman C, Atala A, Soker S. Liver-Tumor Hybrid Organoids for Modeling Tumor Growth and Drug Response In Vitro. Ann Biomed Eng. 2015 Oct; 43(10):2361-73.
Score: 0.031